Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266 BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266
ASK
Publication
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266 BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266
ASK
Publication
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266 BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266
ASK
Publication
BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266 BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266
ASK
Publication
ANA8PRO.CE ANA 8 parameters profile DiaPro 12 Testa 1765 ANA8PRO.CE ANA 8 parameters profile DiaPro 12 Testa 1765
ASK
Publication
ENA6PRO.CE ENA 6 parameters profile DiaPro 12 Testa 1765 ENA6PRO.CE ENA 6 parameters profile DiaPro 12 Testa 1765
ASK
Publication
CTP-100 Laboratory supplies and fixtures: HD Clear(TM) Sealing Tape, 1.88 inches wide Jena Bioscience 1roll 42 CTP-100 Laboratory supplies and fixtures: HD Clear(TM) Sealing Tape, 1.88 inches wide Jena Bioscience 1roll 42
ASK
Publication
SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266
ASK
Publication
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266
ASK
Publication
305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65 305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65
ASK
Publication
M0877 MarkerGeneTM beta Glucuronidase (GUS) Reporter Gene Activity Detection Kit, Allows for quantitative measurement of GUS enzyme activity in transformed plants though the use of a fluorogenic substrate, MarkerGene 350 M0877 MarkerGeneTM beta Glucuronidase (GUS) Reporter Gene Activity Detection Kit, Allows for quantitative measurement of GUS enzyme activity in transformed plants though the use of a fluorogenic substrate, MarkerGene 350
ASK
Publication
K332-100 HAT Activity Activity Assay Kit Biovision 100 assays 396 K332-100 HAT Activity Activity Assay Kit Biovision 100 assays 396
ASK
Publication
K335-100 SOD Activity Activity Assay Kit Biovision 100 assays 299 K335-100 SOD Activity Activity Assay Kit Biovision 100 assays 299 Publication
M1045 MarkerGeneTM Live Cell Glutathione Transferase Activity Kit, Measures glutathione transferase activity in live cells, tissues or cell lysate samples, 1 kit MarkerGene 249 M1045 MarkerGeneTM Live Cell Glutathione Transferase Activity Kit, Measures glutathione transferase activity in live cells, tissues or cell lysate samples, 1 kit MarkerGene 249
ASK
Publication
AR-0106-02 Newcastle Disease Virus (NDV) Real Time PCR Kit RNA III, IV Liferiver 25 349.65 AR-0106-02 Newcastle Disease Virus (NDV) Real Time PCR Kit RNA III, IV Liferiver 25 349.65
ASK
Publication
DS-MB-03442 Mouse Anti-Marek's Disease Virus Ray Biotech 200 604 DS-MB-03442 Mouse Anti-Marek's Disease Virus Ray Biotech 200 604
ASK
Publication
DS-MB-03465 Mouse Anti-Newcastle Disease Virus Ray Biotech 200 541 DS-MB-03465 Mouse Anti-Newcastle Disease Virus Ray Biotech 200 541
ASK
Publication
K335-100 SOD Activity Assay Kit Biovision 100 assays 279 K335-100 SOD Activity Assay Kit Biovision 100 assays 279 Publication
K783-100 MMP-3 Activity Assay Kit Biovision 100 assays 425 K783-100 MMP-3 Activity Assay Kit Biovision 100 assays 425 Publication
POPAIKT Porcine PAI 1 activity ELISA kit Molecular Innovations 1 kit 571.2 POPAIKT Porcine PAI 1 activity ELISA kit Molecular Innovations 1 kit 571.2 Publication
BRD181 Breast disease tissue array, 18 cases 18 cores US Biomax 118 BRD181 Breast disease tissue array, 18 cases 18 cores US Biomax 118
ASK
Publication
LUD151 Lung disease tissue array, 15 cases 15 cores US Biomax 166 LUD151 Lung disease tissue array, 15 cases 15 cores US Biomax 166
ASK
Publication
MD-05-0350 Mouse Anti-Newcastle Disease Virus (NDV) Antibodies Ray Biotech 1 mg 535 MD-05-0350 Mouse Anti-Newcastle Disease Virus (NDV) Antibodies Ray Biotech 1 mg 535 Publication
MD-14-0918 Mouse Anti-Marek Disease Virus Antibodies Ray Biotech 1 mg 568 MD-14-0918 Mouse Anti-Marek Disease Virus Antibodies Ray Biotech 1 mg 568
ASK
Publication
MD-14-1053 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386 MD-14-1053 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386
ASK
Publication
MD-14-1054 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386 MD-14-1054 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386
ASK
Publication
MD-14-1055 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 370 MD-14-1055 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 370
ASK
Publication
SKD241 Skin disease tissue array, 24 cases 24 cores US Biomax 166 SKD241 Skin disease tissue array, 24 cases 24 cores US Biomax 166
ASK
Publication
THD181 Thyroid disease tissue array, 18 cases 18 cores US Biomax 142 THD181 Thyroid disease tissue array, 18 cases 18 cores US Biomax 142
ASK
Publication
K033-F1 Catalase Fluorescent Activity kit Arbor Assays two 96-well plates 321.542 K033-F1 Catalase Fluorescent Activity kit Arbor Assays two 96-well plates 321.542 Publication
K140-100 Cathepsin B Activity Assay Kit Biovision 100 assays 357 K140-100 Cathepsin B Activity Assay Kit Biovision 100 assays 357
ASK
Publication
K141-100 Cathepsin K Activity Assay Kit Biovision 100 assays 357 K141-100 Cathepsin K Activity Assay Kit Biovision 100 assays 357
ASK
Publication
K142-100 Cathepsin L Activity Assay Kit Biovision 100 assays 357 K142-100 Cathepsin L Activity Assay Kit Biovision 100 assays 357
ASK
Publication
K143-100 Cathepsin D Activity Assay Kit Biovision 100 assays 357 K143-100 Cathepsin D Activity Assay Kit Biovision 100 assays 357
ASK
Publication
K144-100 Cathepsin S Activity Assay Kit Biovision 100 assays 357 K144-100 Cathepsin S Activity Assay Kit Biovision 100 assays 357
ASK
Publication
K145-100 Cathepsin H Activity Assay Kit Biovision 100 assays 357 K145-100 Cathepsin H Activity Assay Kit Biovision 100 assays 357
ASK
Publication
K240-100 Calpain Activity Assay Kit Biovision 100 assays 435 K240-100 Calpain Activity Assay Kit Biovision 100 assays 435
ASK
Publication
K245-100 Proteasome Activity Assay Kit Biovision 100 assays 367 K245-100 Proteasome Activity Assay Kit Biovision 100 assays 367 Publication
K260-100 GST Fluorometric Activity Assay Kit Biovision 100 assays 367 K260-100 GST Fluorometric Activity Assay Kit Biovision 100 assays 367
ASK
Publication
K263-100 GST Colorimetric Activity Assay Kit Biovision 100 assays 367 K263-100 GST Colorimetric Activity Assay Kit Biovision 100 assays 367
ASK
Publication
K371-100 cAMP Activity Assay Kit Biovision 100 assays 367 K371-100 cAMP Activity Assay Kit Biovision 100 assays 367 Publication
K372-100 cGMP Activity Assay Kit Biovision 100 assays 367 K372-100 cGMP Activity Assay Kit Biovision 100 assays 367
ASK
Publication
K430-40 KinaseSTAR JNK Activity Screening Kit Biovision 40 assays 559 K430-40 KinaseSTAR JNK Activity Screening Kit Biovision 40 assays 559 Publication
K431-40 KinaseSTAR JNK Activity Assay Kit Biovision 40 assays 687 K431-40 KinaseSTAR JNK Activity Assay Kit Biovision 40 assays 687 Publication
K435-40 KinaseSTAR Akt Activity Assay Kit Biovision 40 assays 687 K435-40 KinaseSTAR Akt Activity Assay Kit Biovision 40 assays 687 Publication
K601-100 CETP Activity Assay Kit Biovision 100 assays 464 K601-100 CETP Activity Assay Kit Biovision 100 assays 464
ASK
Publication
K604-100 PLTP Activity Assay Kit Biovision 100 assays 464 K604-100 PLTP Activity Assay Kit Biovision 100 assays 464 Publication
K711-100 Amylase Activity Assay Kit Biovision 100 assays 269 K711-100 Amylase Activity Assay Kit Biovision 100 assays 269 Publication
K716-100 Aconitase Activity Assay Kit Biovision 100 assays 357 K716-100 Aconitase Activity Assay Kit Biovision 100 assays 357 Publication
K722-100 Lipase Activity Assay Kit Biovision 100 assays 357 K722-100 Lipase Activity Assay Kit Biovision 100 assays 357 Publication
K723-100 Lipase Activity Assay Kit II Biovision 100 assays 386 K723-100 Lipase Activity Assay Kit II Biovision 100 assays 386 Publication
K724-100 Lipase Activity Assay Kit III Biovision 100 assays 425 K724-100 Lipase Activity Assay Kit III Biovision 100 assays 425 Publication
K754-100 Asparaginase Activity Assay Kit Biovision 100 assays 425 K754-100 Asparaginase Activity Assay Kit Biovision 100 assays 425 Publication
K771-100 Trypsin Activity Assay Kit Biovision 100 assays 308 K771-100 Trypsin Activity Assay Kit Biovision 100 assays 308 Publication
K773-100 Catalase Activity Assay Kit Biovision 100 assays 289 K773-100 Catalase Activity Assay Kit Biovision 100 assays 289 Publication
K779-100 DPP4 Activity Assay Kit Biovision 100 assays 386 K779-100 DPP4 Activity Assay Kit Biovision 100 assays 386
ASK
Publication
K781-100 Protease Activity Assay Kit Biovision 100 assays 289 K781-100 Protease Activity Assay Kit Biovision 100 assays 289 Publication
AGHIV-0210 rHIV gp36, insoluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 510 AGHIV-0210 rHIV gp36, insoluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 510
ASK
Publication
AGHIV-0215 rHIV gp36, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 466 AGHIV-0215 rHIV gp36, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 466
ASK
Publication
AGHIV-0225 rHIV gp41, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 479 AGHIV-0225 rHIV gp41, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 479
ASK
Publication
DID381 Digestive system disease tissue array, 38 cases 38 cores US Biomax 166 DID381 Digestive system disease tissue array, 38 cases 38 cores US Biomax 166
ASK
Publication
DS-MB-02741 Mouse Anti-Foot-and-Mouth Disease Virus Serotype O1 Ray Biotech 200 604 DS-MB-02741 Mouse Anti-Foot-and-Mouth Disease Virus Serotype O1 Ray Biotech 200 604
ASK
Publication
HND181 Head and neck disease tissue array, 18 cases 18 cores US Biomax 166 HND181 Head and neck disease tissue array, 18 cases 18 cores US Biomax 166
ASK
Publication
HNT961 Head and neck disease tissue array, 48 cases 96 cores US Biomax 225 HNT961 Head and neck disease tissue array, 48 cases 96 cores US Biomax 225
ASK
Publication
LUD481 Lung disease and normal tissue array, 16 cases 48 cores US Biomax 225 LUD481 Lung disease and normal tissue array, 16 cases 48 cores US Biomax 225
ASK
Publication
MD-14-0860 Mouse Anti-Foot and Mouth Disease Virus NS Antibodies Ray Biotech 1 mg 452 MD-14-0860 Mouse Anti-Foot and Mouth Disease Virus NS Antibodies Ray Biotech 1 mg 452
ASK
Publication
TH807 Thyroid disease spectrum tissue array, 75 cases 80 cores US Biomax 266 TH807 Thyroid disease spectrum tissue array, 75 cases 80 cores US Biomax 266
ASK
Publication
13512 Amplite™ MMP 3 Activity Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 280 13512 Amplite™ MMP 3 Activity Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 280
ASK
Publication
2227 ANTI ACTIVATED X FACTOR ACTIVITY, PLASMA Keynova 1 80.682 2227 ANTI ACTIVATED X FACTOR ACTIVITY, PLASMA Keynova 1 80.682
ASK
Publication
4700-096-K Tankyrase 1 Colorimetric Activity Assay Trevigen 96 samples 996 4700-096-K Tankyrase 1 Colorimetric Activity Assay Trevigen 96 samples 996 Publication
4700-192-K Tankyrase 1 Colorimetric Activity Assay Trevigen 192 samples 1342 4700-192-K Tankyrase 1 Colorimetric Activity Assay Trevigen 192 samples 1342
ASK
Publication
4701-096-K Tankyrase 1 Chemiluminescent Activity Assay Trevigen 96 samples 996 4701-096-K Tankyrase 1 Chemiluminescent Activity Assay Trevigen 96 samples 996 Publication
4701-192-K Tankyrase 1 Chemiluminescent Activity Assay Trevigen 192 samples 1342 4701-192-K Tankyrase 1 Chemiluminescent Activity Assay Trevigen 192 samples 1342 Publication
K033-F1 Catalase Fluorescent Activity kit (Two Plates) Arbor Assays 2 x 96 well plate 310 K033-F1 Catalase Fluorescent Activity kit (Two Plates) Arbor Assays 2 x 96 well plate 310 Publication
K033-H1 Catalase Colorimetric Activity kit (Two Plates) Arbor Assays 2 x 96 well plate 310 K033-H1 Catalase Colorimetric Activity kit (Two Plates) Arbor Assays 2 x 96 well plate 310 Publication
K035-H1 Ceruloplasmin Colorimetric Activity Kit (Two Plates) Arbor Assays 2 x 96 well plate 398 K035-H1 Ceruloplasmin Colorimetric Activity Kit (Two Plates) Arbor Assays 2 x 96 well plate 398 Publication
K3015-1 Acetylcholinesterase (AChE) Fluorescent Activity Kit B-Bridge 192 rxns 339 K3015-1 Acetylcholinesterase (AChE) Fluorescent Activity Kit B-Bridge 192 rxns 339
ASK
Publication
K330-100 HDAC Fluorometric Activity Assay Kit Biovision 100 assays 357 K330-100 HDAC Fluorometric Activity Assay Kit Biovision 100 assays 357
ASK
Publication
K331-100 HDAC Colorimetric Activity Assay Kit Biovision 100 assays 357 K331-100 HDAC Colorimetric Activity Assay Kit Biovision 100 assays 357
ASK
Publication
K709-100 Pyruvate Kinase Activity Assay Kit Biovision 100 assays 435 K709-100 Pyruvate Kinase Activity Assay Kit Biovision 100 assays 435 Publication
K710-100 Xanthine Oxidase Activity Assay Kit Biovision 100 assays 289 K710-100 Xanthine Oxidase Activity Assay Kit Biovision 100 assays 289 Publication
K726-500 Lactate Dehydrogenase Activity Assay Kit Biovision 500 assays 367 K726-500 Lactate Dehydrogenase Activity Assay Kit Biovision 500 assays 367 Publication
K744-100 Myeloperoxidase (MPO) Colorimetric Activity Assay Kit Biovision 100 assays 406 K744-100 Myeloperoxidase (MPO) Colorimetric Activity Assay Kit Biovision 100 assays 406 Publication
K745-100 Myeloperoxidase (MPO) Fluorometric Activity Assay Kit Biovision 100 assays 406 K745-100 Myeloperoxidase (MPO) Fluorometric Activity Assay Kit Biovision 100 assays 406 Publication
K756-100 Isocitrate Dehydrogenase Activity Assay Kit Biovision 100 assays 357 K756-100 Isocitrate Dehydrogenase Activity Assay Kit Biovision 100 assays 357 Publication
K761-200 Glutathione Reductase Activity Assay Kit Biovision 200 assays 357 K761-200 Glutathione Reductase Activity Assay Kit Biovision 200 assays 357 Publication
K762-100 Glutathione Peroxidase Activity Assay Kit Biovision 100 assays 357 K762-100 Glutathione Peroxidase Activity Assay Kit Biovision 100 assays 357 Publication
K786-100 Glucose Dehydrogenase Activity Assay Kit Biovision 100 assays 367 K786-100 Glucose Dehydrogenase Activity Assay Kit Biovision 100 assays 367 Publication
K787-100 Alcohol Dehydrogenase Activity Assay Kit Biovision 100 assays 386 K787-100 Alcohol Dehydrogenase Activity Assay Kit Biovision 100 assays 386 Publication
CVD231 Cardiovascular disease tissue array, non overlapping with CVD481, 23 cases 23 cores US Biomax 166 CVD231 Cardiovascular disease tissue array, non overlapping with CVD481, 23 cases 23 cores US Biomax 166
ASK
Publication
CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores US Biomax 189 CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores US Biomax 189
ASK
Publication
ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases 208 cores US Biomax 456 ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases 208 cores US Biomax 456
ASK
Publication
IPLA-DIBP Disease State Samples: Single Donor Human Diabetic Plasma Innovative Research INC 1ml 342 IPLA-DIBP Disease State Samples: Single Donor Human Diabetic Plasma Innovative Research INC 1ml 342 Publication
LP802 Laryngeal disease spectrum (progression) tissue array, 78 cases 80 cores US Biomax 278 LP802 Laryngeal disease spectrum (progression) tissue array, 78 cases 80 cores US Biomax 278
ASK
Publication
MD-14-0747 Mouse Anti-B. burgdorferi sensu stricto (Lyme disease) Antibodies Ray Biotech 1 mg 411 MD-14-0747 Mouse Anti-B. burgdorferi sensu stricto (Lyme disease) Antibodies Ray Biotech 1 mg 411
ASK
Publication
UGD381 Urinary genital system disease tissue array, 38 cases 38 cores US Biomax 166 UGD381 Urinary genital system disease tissue array, 38 cases 38 cores US Biomax 166
ASK
Publication
13511 Amplite™ Universal Fluorimetric MMP Activity Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 280 13511 Amplite™ Universal Fluorimetric MMP Activity Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 280
ASK
Publication
AQT1352 Human Glucocorticoid Receptor Activity Test Orgenium 96 Tests 1050 AQT1352 Human Glucocorticoid Receptor Activity Test Orgenium 96 Tests 1050
ASK
Publication
CAN-PRA-7060 CLIA Human Serum Renin Activity DBC 96 Wells/Kit 280 CAN-PRA-7060 CLIA Human Serum Renin Activity DBC 96 Wells/Kit 280
ASK
Publication
K011-F1 P450 Demethylation Activity kit (2 plate) Arbor Assays 2x96 well plates 270 K011-F1 P450 Demethylation Activity kit (2 plate) Arbor Assays 2x96 well plates 270
ASK
Publication
K015-F1 Acetylcholinesterase Fluorescent Activity kit (2 plate) Arbor Assays 2x96 well plates 293 K015-F1 Acetylcholinesterase Fluorescent Activity kit (2 plate) Arbor Assays 2x96 well plates 293
ASK
Publication
K016-F1 Buyrylcholinesterase Fluorescent Activity kit (2 plate) Arbor Assays 2x96 well plates 296 K016-F1 Buyrylcholinesterase Fluorescent Activity kit (2 plate) Arbor Assays 2x96 well plates 296 Publication
K027-H1 PKA (Protein Kinase A) Activity Assay kit Arbor Assays 1x96 well plate 398 K027-H1 PKA (Protein Kinase A) Activity Assay kit Arbor Assays 1x96 well plate 398 Publication
K028-H1 Superoxide Dismutase (SOD) Colorimetric Activity kit (2 Plates) Arbor Assays 2 x 96 well plate 337 K028-H1 Superoxide Dismutase (SOD) Colorimetric Activity kit (2 Plates) Arbor Assays 2 x 96 well plate 337 Publication
K422-500 Alkaline Phosphatase Activity Fluorometric Assay Kit Biovision 500 assays 260 K422-500 Alkaline Phosphatase Activity Fluorometric Assay Kit Biovision 500 assays 260 Publication
K752-100 Alanine Aminotransferase (ALT or SGPT) Activity Assay Kit Biovision 100 assays 357 K752-100 Alanine Aminotransferase (ALT or SGPT) Activity Assay Kit Biovision 100 assays 357 Publication
K753-100 Aspartate Aminotransferase (AST or SGOT) Activity Assay Kit Biovision 100 assays 357 K753-100 Aspartate Aminotransferase (AST or SGOT) Activity Assay Kit Biovision 100 assays 357 Publication
K757-100 Glucose-6-Phosphate Dehydrogenase Activity Assay Kit Biovision 100 assays 357 K757-100 Glucose-6-Phosphate Dehydrogenase Activity Assay Kit Biovision 100 assays 357 Publication
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231 BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231
ASK
Publication
IPLA-ADPF Disease State Samples: Single Donor Human Atopic Dermatitis Plasma Innovative Research INC 1ml 342 IPLA-ADPF Disease State Samples: Single Donor Human Atopic Dermatitis Plasma Innovative Research INC 1ml 342
ASK
Publication
KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases 208 cores US Biomax 456 KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases 208 cores US Biomax 456
ASK
Publication
MSP20 Rapid Microplate Assay Kit for PDH Activity and Quantity (Combo) ACR 96 Tests 988.05 MSP20 Rapid Microplate Assay Kit for PDH Activity and Quantity (Combo) ACR 96 Tests 988.05 Publication
13501 Amplite™ Universal Fluorimetric Protease Activity Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 202 13501 Amplite™ Universal Fluorimetric Protease Activity Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 202 Publication
13510 Amplite™ Universal Fluorimetric MMP Activity Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 280 13510 Amplite™ Universal Fluorimetric MMP Activity Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 280
ASK
Publication
13601 Amplite™ Fluorimetric HDAC Activity Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 202 13601 Amplite™ Fluorimetric HDAC Activity Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 202
ASK
Publication
K784-100 Gamma Glutamyl Transferase (GGT) Activity Colorimetric Assay Kit Biovision 100 assays 406 K784-100 Gamma Glutamyl Transferase (GGT) Activity Colorimetric Assay Kit Biovision 100 assays 406 Publication
M0611 3 Carboxyumbelliferone galactoside BSA conjugate, Extracellular Galactosidase Activity Detector, 2mg MarkerGene 159 M0611 3 Carboxyumbelliferone galactoside BSA conjugate, Extracellular Galactosidase Activity Detector, 2mg MarkerGene 159
ASK
Publication
M1238 Resorufin cellobioside, Fluorogenic substrate for detection of cellulase activity, 5mg MarkerGene 165 M1238 Resorufin cellobioside, Fluorogenic substrate for detection of cellulase activity, 5mg MarkerGene 165
ASK
Publication
MSP20 Rapid Microplate Assay Kit for PDH Activity and Quantity (Combo) ACR 96 Tests 830.55 MSP20 Rapid Microplate Assay Kit for PDH Activity and Quantity (Combo) ACR 96 Tests 830.55 Publication
P-3021-48 EpiQuik MBD2 Binding Activity Inhibition Assay Kit EpigenTek 48 assays 505.449 P-3021-48 EpiQuik MBD2 Binding Activity Inhibition Assay Kit EpigenTek 48 assays 505.449
ASK
Publication
P-3021-48  EpiQuik MBD2 Binding Activity Inhibition Assay Kit (48 assays) EpigenTek 474.6 P-3021-48  EpiQuik MBD2 Binding Activity Inhibition Assay Kit (48 assays) EpigenTek 474.6
ASK
Publication
BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases 80 cores US Biomax 266 BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases 208 cores US Biomax 236 GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases 208 cores US Biomax 236
ASK
Publication
KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases 80 cores US Biomax 231 KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases 80 cores US Biomax 231
ASK
Publication
LC1201 Lung disease spectrum tissue array, 116 cases 120 cores, with grade and stage information US Biomax 278 LC1201 Lung disease spectrum tissue array, 116 cases 120 cores, with grade and stage information US Biomax 278
ASK
Publication
LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases 208 cores US Biomax 456 LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases 208 cores US Biomax 456
ASK
Publication
LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores US Biomax 225 LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores US Biomax 225
ASK
Publication
LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases 80 cores US Biomax 231 LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases 80 cores US Biomax 231
ASK
Publication
LV2081 Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 cores US Biomax 516 LV2081 Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 cores US Biomax 516
ASK
Publication
LV8011 Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 cores US Biomax 231 LV8011 Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 cores US Biomax 231
ASK
Publication
PR805 Prostate disease spectrum (prostatic cancer progression) tissue array, 80 cases 80 cores US Biomax 266 PR805 Prostate disease spectrum (prostatic cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
RE2081 Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores US Biomax 456 RE2081 Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores US Biomax 456
ASK
Publication
RE804 Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores US Biomax 231 RE804 Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores US Biomax 231
ASK
Publication
SK2081 Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases 208 cores US Biomax 456 SK2081 Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases 208 cores US Biomax 456
ASK
Publication
SK805 Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores US Biomax 266 SK805 Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores US Biomax 266
ASK
Publication
SM2081 Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores US Biomax 456 SM2081 Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores US Biomax 456
ASK
Publication
SP1001 Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores US Biomax 266 SP1001 Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
TE803 Testis disease spectrum (testicular cancer progression) tissue array, 80 cases 80 cores US Biomax 266 TE803 Testis disease spectrum (testicular cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
THY761 Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases 76 cores US Biomax 266 THY761 Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases 76 cores US Biomax 266
ASK
Publication
UV1001 Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores US Biomax 266 UV1001 Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores US Biomax 266
ASK
Publication
13500 Amplite™ Universal Fluorimetric Protease Activity Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 202 13500 Amplite™ Universal Fluorimetric Protease Activity Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 202
ASK
Publication
22795 Cell Meter™ Caspase 3 7 Activity Apoptosis Assay Kit * Blue Fluorescence* AAT Bioquest 1 kit 130 22795 Cell Meter™ Caspase 3 7 Activity Apoptosis Assay Kit * Blue Fluorescence* AAT Bioquest 1 kit 130
ASK
Publication
22796 Cell Meter™ Caspase 3 7 Activity Apoptosis Assay Kit * Green Fluorescence* AAT Bioquest 1 kit 212 22796 Cell Meter™ Caspase 3 7 Activity Apoptosis Assay Kit * Green Fluorescence* AAT Bioquest 1 kit 212
ASK
Publication
22797 Cell Meter™ Caspase 3 7 Activity Apoptosis Assay Kit *Red Fluorescence* AAT Bioquest 100 Tests 280 22797 Cell Meter™ Caspase 3 7 Activity Apoptosis Assay Kit *Red Fluorescence* AAT Bioquest 100 Tests 280
ASK
Publication
22798 Cell Meter™ Caspase 8 Activity Apoptosis Assay Kit * Green Fluorescence* AAT Bioquest 1 kit 212 22798 Cell Meter™ Caspase 8 Activity Apoptosis Assay Kit * Green Fluorescence* AAT Bioquest 1 kit 212
ASK
Publication
22812 Cell Meter™ Caspase 9 Activity Apoptosis Assay Kit * Blue Fluorescence* AAT Bioquest 1 kit 215 22812 Cell Meter™ Caspase 9 Activity Apoptosis Assay Kit * Blue Fluorescence* AAT Bioquest 1 kit 215
ASK
Publication
22813 Cell Meter™ Caspase 9 Activity Apoptosis Assay Kit * Green Fluorescence* AAT Bioquest 1 kit 215 22813 Cell Meter™ Caspase 9 Activity Apoptosis Assay Kit * Green Fluorescence* AAT Bioquest 1 kit 215
ASK
Publication
22816 Cell Meter™ Caspase 8 Activity Apoptosis Assay Kit *Red Fluorescence* AAT Bioquest 100 Tests 202 22816 Cell Meter™ Caspase 8 Activity Apoptosis Assay Kit *Red Fluorescence* AAT Bioquest 100 Tests 202
ASK
Publication
22817 Cell Meter™ Caspase 9 Activity Apoptosis Assay Kit *Red Fluorescence* AAT Bioquest 100 Tests 202 22817 Cell Meter™ Caspase 9 Activity Apoptosis Assay Kit *Red Fluorescence* AAT Bioquest 100 Tests 202
ASK
Publication
M1087 D Luciferin 6 0 ß D Galactopyranoside, Ultrasensitive substrate for chemiluminescent measurement of galactosidase activity, 5mg MarkerGene 258 M1087 D Luciferin 6 0 ß D Galactopyranoside, Ultrasensitive substrate for chemiluminescent measurement of galactosidase activity, 5mg MarkerGene 258
ASK
Publication
P-3002-1 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K4 EpigenTek 48 assays 461 P-3002-1 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K4 EpigenTek 48 assays 461 Publication
P-3002-2 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K4 EpigenTek 96 assays 769.65 P-3002-2 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K4 EpigenTek 96 assays 769.65 Publication
P-3003-1 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K9 EpigenTek 48 assays 461 P-3003-1 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K9 EpigenTek 48 assays 461 Publication
P-3003-2 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K9 EpigenTek 96 assays 770 P-3003-2 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K9 EpigenTek 96 assays 770 Publication
P-3005-48 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K27 EpigenTek 48 assays 461 P-3005-48 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K27 EpigenTek 48 assays 461 Publication
P-3005-96 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K27 EpigenTek 96 assays 770 P-3005-96 EpiQuik Histone Methyltransferase Activity Inhibition Assay Kit H3K27 EpigenTek 96 assays 770 Publication
OR801 Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases 80 cores US Biomax 266 OR801 Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores US Biomax 266 SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
TE2081 Testis disease spectrum (testicular cancer progression) tissue array, with TNM data, 104 cases 208 cores US Biomax 456 TE2081 Testis disease spectrum (testicular cancer progression) tissue array, with TNM data, 104 cases 208 cores US Biomax 456
ASK
Publication
UR1001 Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores US Biomax 199 UR1001 Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores US Biomax 199
ASK
Publication
22799 Cell Meter™ Caspase 9 Activity Apoptosis Assay Kit *Green Fluorescence* AAT Bioquest 200 Tests 280 22799 Cell Meter™ Caspase 9 Activity Apoptosis Assay Kit *Green Fluorescence* AAT Bioquest 200 Tests 280
ASK
Publication
22820 Cell Meter™ Caspase 3 7, 8 and 9 Activity Multiplexing Assay Kit *Tricolor Fluorescence* AAT Bioquest 100 Tests 280 22820 Cell Meter™ Caspase 3 7, 8 and 9 Activity Multiplexing Assay Kit *Tricolor Fluorescence* AAT Bioquest 100 Tests 280
ASK
Publication
22900 Cell Meter™ Fluorimetric Intracellular Total ROS Activity Assay Kit*Green Fluorescence* AAT Bioquest 1 kit 202 22900 Cell Meter™ Fluorimetric Intracellular Total ROS Activity Assay Kit*Green Fluorescence* AAT Bioquest 1 kit 202
ASK
Publication
22901 Cell Meter™ Fluorimetric Intracellular Total ROS Activity Assay Kit*Orange Fluorescence* AAT Bioquest 1 kit 215 22901 Cell Meter™ Fluorimetric Intracellular Total ROS Activity Assay Kit*Orange Fluorescence* AAT Bioquest 1 kit 215
ASK
Publication
M1194 2, 7 Dichlorofluorescein di galactoside, Fluorescent substrate for measuring galactosidase and galactocerebrosidase activity, 25mg MarkerGene 155 M1194 2, 7 Dichlorofluorescein di galactoside, Fluorescent substrate for measuring galactosidase and galactocerebrosidase activity, 25mg MarkerGene 155 Publication
  OP-0001-2  EpiQuik Superoxide Dismutase Activity Inhibition Assay Kit (Colorimetric) (2x96 assays) EpigenTek 240   OP-0001-2  EpiQuik Superoxide Dismutase Activity Inhibition Assay Kit (Colorimetric) (2x96 assays) EpigenTek 240
ASK
Publication
  OP-0001-3  EpiQuik Superoxide Dismutase Activity Inhibition Assay Kit (Colorimetric) (5x96 assays) EpigenTek 397   OP-0001-3  EpiQuik Superoxide Dismutase Activity Inhibition Assay Kit (Colorimetric) (5x96 assays) EpigenTek 397
ASK
Publication
BR722 Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages US Biomax 231 BR722 Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages US Biomax 231
ASK
Publication
MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160 MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160
ASK
Publication
PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314 PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314
ASK
Publication
M1389 MarkerGene™ Cellular Senescence Assay Kit, Can be used to monitor and detect â galactosidase activity in senescent cells at pH 6.0 using X Gal, 1 kit MarkerGene 317 M1389 MarkerGene™ Cellular Senescence Assay Kit, Can be used to monitor and detect â galactosidase activity in senescent cells at pH 6.0 using X Gal, 1 kit MarkerGene 317
ASK
Publication
A80059Mu01 Antibody to Parkinson Disease Protein 7 (PARK7) Organism: Mus musculus (Mouse) Type: Polyclonal Source: Rabbit USCNLife 50ug 340 A80059Mu01 Antibody to Parkinson Disease Protein 7 (PARK7) Organism: Mus musculus (Mouse) Type: Polyclonal Source: Rabbit USCNLife 50ug 340
ASK
Publication
22822 Cell Meter™ Generic Fluorometric Caspase Activity Assay Kit *Optimized Red Fluorescence for Flow Cytometry* AAT Bioquest 1 kit 231 22822 Cell Meter™ Generic Fluorometric Caspase Activity Assay Kit *Optimized Red Fluorescence for Flow Cytometry* AAT Bioquest 1 kit 231
ASK
Publication
22823 Cell Meter™ Fluorometric Caspase 3 7 Activity Assay Kit *Green Fluorescence Optimized for Flow Cytometry* AAT Bioquest 1 kit 231 22823 Cell Meter™ Fluorometric Caspase 3 7 Activity Assay Kit *Green Fluorescence Optimized for Flow Cytometry* AAT Bioquest 1 kit 231
ASK
Publication
M1208 Resorufin Oleate, Fluorogenic substrate with red emission for use in detection of intracellular and in vitro lipase activity, 10mg MarkerGene 150 M1208 Resorufin Oleate, Fluorogenic substrate with red emission for use in detection of intracellular and in vitro lipase activity, 10mg MarkerGene 150
ASK
Publication
22821 Cell Meter™ Generic Fluorometric Caspase Activity Assay Kit *Optimized Green Fluorescence for Flow Cytometry* AAT Bioquest 1 kit 231 22821 Cell Meter™ Generic Fluorometric Caspase Activity Assay Kit *Optimized Green Fluorescence for Flow Cytometry* AAT Bioquest 1 kit 231
ASK
Publication
M1352 MarkerGene™ â Galactosidase Staining Kit, used to monitor and detect enzyme activity in stably or transiently transfected cells or transgenic tissues using X Gal, 1 kit MarkerGene 240 M1352 MarkerGene™ â Galactosidase Staining Kit, used to monitor and detect enzyme activity in stably or transiently transfected cells or transgenic tissues using X Gal, 1 kit MarkerGene 240
ASK
Publication
M1388 4 Methylumbelliferyl sulfate, potassium salt, Highly sensitive fluorescent substrate for monitoring aryl sulfatase activity, 25mg MarkerGene 90 M1388 4 Methylumbelliferyl sulfate, potassium salt, Highly sensitive fluorescent substrate for monitoring aryl sulfatase activity, 25mg MarkerGene 90
ASK
Publication
290-62601 Beta Amyloid (42) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55 290-62601 Beta Amyloid (42) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55
ASK
Publication
292-62301 Beta Amyloid (1 40) ELISA Kit, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. The B-Bridge 96 tests 1040.55 292-62301 Beta Amyloid (1 40) ELISA Kit, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. The B-Bridge 96 tests 1040.55
ASK
Publication
294-62501 Beta Amyloid (40) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55 294-62501 Beta Amyloid (40) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55
ASK
Publication
298-64601 Beta Amyloid (1 40) ELISA Kit II, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. T B-Bridge 96 tests 1040.55 298-64601 Beta Amyloid (1 40) ELISA Kit II, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. T B-Bridge 96 tests 1040.55
ASK
Publication
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314 BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314
ASK
Publication
BR480 Breast disease spectrum tissue array progression array, 48 cases 48 cores US Biomax 314 BR480 Breast disease spectrum tissue array progression array, 48 cases 48 cores US Biomax 314
ASK
Publication
LM801 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores US Biomax 266 LM801 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
SFD241 Human soft tissue disease tissue array, 24 cases 24 cores US Biomax 166 SFD241 Human soft tissue disease tissue array, 24 cases 24 cores US Biomax 166
ASK
Publication
BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores US Biomax 456 BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores US Biomax 456
ASK
Publication
BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores US Biomax 516 BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores US Biomax 516
ASK
Publication
BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores US Biomax 456 BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores US Biomax 456
ASK
Publication
CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores US Biomax 225 CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores US Biomax 225
ASK
Publication
CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases 80 cores US Biomax 266 CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases 80 cores US Biomax 266
ASK
Publication
ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases 80 cores US Biomax 231 ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases 80 cores US Biomax 231
ASK
Publication
GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases 80 cores US Biomax 123 GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases 80 cores US Biomax 123
ASK
Publication
HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266 HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
LM802 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803 US Biomax 266 LM802 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803 US Biomax 266
ASK
Publication
NH1001 Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases 100 cores US Biomax 266 NH1001 Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases 100 cores US Biomax 266
ASK
Publication
OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores US Biomax 266 OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases 60 cores US Biomax 266 PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases 60 cores US Biomax 266
ASK
Publication
ST1001 Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores US Biomax 266 ST1001 Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores US Biomax 266
ASK
Publication
UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases 80 cores US Biomax 278 UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases 80 cores US Biomax 278
ASK
Publication
AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores US Biomax 456 AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores US Biomax 456
ASK
Publication
OR2081 Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases 208 cores US Biomax 456 OR2081 Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases 208 cores US Biomax 456
ASK
Publication
ST8011 Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases 80 cores US Biomax 266 ST8011 Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
OV1001 Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005 US Biomax 231 OV1001 Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005 US Biomax 231
ASK
Publication
SO8011 Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases 80 cores US Biomax 278 SO8011 Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases 80 cores US Biomax 278
ASK
Publication
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321 BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321
ASK
Publication
BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321 BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321
ASK
Publication
CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores US Biomax 314 CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores US Biomax 314
ASK
Publication
CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456 CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456
ASK
Publication
PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores US Biomax 456 PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores US Biomax 456
ASK
Publication
CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602 US Biomax 231 CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602 US Biomax 231
ASK
Publication
LM208 High density tissue microarray of Hodgkin's Disease, Non Hodgkin's lymphoma and normal lymph node tissues, 69 cases 208 cores US Biomax 456 LM208 High density tissue microarray of Hodgkin's Disease, Non Hodgkin's lymphoma and normal lymph node tissues, 69 cases 208 cores US Biomax 456
ASK
Publication
M0802 FMOC D Luciferin, Amino analog of D luciferin substrate for firefly luciferase activity, 5 mg MarkerGene 282 M0802 FMOC D Luciferin, Amino analog of D luciferin substrate for firefly luciferase activity, 5 mg MarkerGene 282
ASK
Publication
DAMY-100 QuantiChrom™ α-Amylase Assay Kit, Quantitative determination of α-amylase activity by colorimetric (595nm) method Bioassays 100Tests 405 DAMY-100 QuantiChrom™ α-Amylase Assay Kit, Quantitative determination of α-amylase activity by colorimetric (595nm) method Bioassays 100Tests 405 Publication
M1319 MarkerGeneTM Fluorescent Protease Assay Kit, Allows quick and simple measurement of general protease activity in biological samples. MarkerGene 261 M1319 MarkerGeneTM Fluorescent Protease Assay Kit, Allows quick and simple measurement of general protease activity in biological samples. MarkerGene 261
ASK
Publication
M0612 MarkerGeneTM Fluorescent Lipase Assay Kit, Allows fast and easy measurement of lipase activity in vitro, in cell preparations or in vivo, 1 kit MarkerGene 380 M0612 MarkerGeneTM Fluorescent Lipase Assay Kit, Allows fast and easy measurement of lipase activity in vitro, in cell preparations or in vivo, 1 kit MarkerGene 380
ASK
Publication
SO2081 Muscle disease spectrum (smooth muscle and striated muscle cancer progression) tissue array, 104 cases 208 cores US Biomax 456 SO2081 Muscle disease spectrum (smooth muscle and striated muscle cancer progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
24068 Primary antibody IL-1RAcP Antibody, Source Rabbit, Species Reactivity It has no cross activity to other member in the IL-1 receptor family. SignalWay Antibody S.A.B 100ug 364 24068 Primary antibody IL-1RAcP Antibody, Source Rabbit, Species Reactivity It has no cross activity to other member in the IL-1 receptor family. SignalWay Antibody S.A.B 100ug 364
ASK
Publication
M0855 MarkerGeneTM Chemiluminescent lacZ beta Galactosidase Detection Kit, Allows for quantitaive measure of b galactosidase enzyme activity in mammalian, yeast, and bacterial cells through the use of a che MarkerGene 347 M0855 MarkerGeneTM Chemiluminescent lacZ beta Galactosidase Detection Kit, Allows for quantitaive measure of b galactosidase enzyme activity in mammalian, yeast, and bacterial cells through the use of a che MarkerGene 347
ASK
Publication
M1376 MarkerGene™ LysoLive™ Lysosomal Phosphatase Assay Kit, Useful for labeling lysosomes in a live cell format and capable of monitoring lysosomal metabolic activity, 1 kit MarkerGene 459 M1376 MarkerGene™ LysoLive™ Lysosomal Phosphatase Assay Kit, Useful for labeling lysosomes in a live cell format and capable of monitoring lysosomal metabolic activity, 1 kit MarkerGene 459
ASK
Publication
DACE-100 QuantiChrom™ Acetylcholinesterase Assay Kit, Quantitative determination of acetylcholinesterase activity by colorimetric (412nm) method. Procedure 10 min. Kit size 100 tests. Detection limit 10 U L Bioassays 100tests 385 DACE-100 QuantiChrom™ Acetylcholinesterase Assay Kit, Quantitative determination of acetylcholinesterase activity by colorimetric (412nm) method. Procedure 10 min. Kit size 100 tests. Detection limit 10 U L Bioassays 100tests 385 Publication
EPPD-100 EnzyChrom™ Phospholipase D Assay Kit, Quantitative determination of phospholipase D activity by colorimetric (570nm) or fluorimetric (530 590nm) method. Procedure 30 min. Kit size 100 tests. Detecti Bioassays 100tests 287 EPPD-100 EnzyChrom™ Phospholipase D Assay Kit, Quantitative determination of phospholipase D activity by colorimetric (570nm) or fluorimetric (530 590nm) method. Procedure 30 min. Kit size 100 tests. Detecti Bioassays 100tests 287 Publication
BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores US Biomax 266 BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores US Biomax 516 CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores US Biomax 516
ASK
Publication
OR802 Oral cavity disease spectrum (oral cavity cancer progression) tissue array, 79 cases 80 cores US Biomax 266 OR802 Oral cavity disease spectrum (oral cavity cancer progression) tissue array, 79 cases 80 cores US Biomax 266
ASK
Publication
SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases 80 cores US Biomax 266 SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
UTE601 Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores US Biomax 266 UTE601 Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores US Biomax 266
ASK
Publication
VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores US Biomax 266 VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266 SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266
ASK
Publication
SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456 SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231 CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231
ASK
Publication
M1214 MarkerGeneTM Long Wavelength Fluorescent Lipase Assay Kit, Allows fast and easy measurement of lipase activity in vitro, in cell preparations or in vivo using the substrate resorufin oleate, 1 kit MarkerGene 380 M1214 MarkerGeneTM Long Wavelength Fluorescent Lipase Assay Kit, Allows fast and easy measurement of lipase activity in vitro, in cell preparations or in vivo using the substrate resorufin oleate, 1 kit MarkerGene 380 Publication
0801517 ESCHERICHIA COLI clinical isolate, titered Zeptometrix ML 476 0801517 ESCHERICHIA COLI clinical isolate, titered Zeptometrix ML 476
ASK
Publication
0801519 PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 0 0801519 PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 0
ASK
Publication
0801650 CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 0 0801650 CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 0
ASK
Publication
24067 Primary antibody IL-1RAcP Antibody, Source Rabbit, Species Reactivity This polyclonal antibody has no cross activity to other members in the IL-1 receptor family. SignalWay Antibody S.A.B 100ug 364 24067 Primary antibody IL-1RAcP Antibody, Source Rabbit, Species Reactivity This polyclonal antibody has no cross activity to other members in the IL-1 receptor family. SignalWay Antibody S.A.B 100ug 364
ASK
Publication
ECAT-100 EnzyChrom™ Catalase Assay Kit, Quantitative determination of catalase activity by colorimetric (570nm) or fluorometric (530nm 590nm) methods. Procedure 40 min. Kit size 100 tests. Detection limit 0 Bioassays 100tests 258 ECAT-100 EnzyChrom™ Catalase Assay Kit, Quantitative determination of catalase activity by colorimetric (570nm) or fluorometric (530nm 590nm) methods. Procedure 40 min. Kit size 100 tests. Detection limit 0 Bioassays 100tests 258 Publication
0801519 BACTERIOLOGY PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 1 0 0801519 BACTERIOLOGY PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 1 0
ASK
Publication
0801650 BACTERIOLOGY CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 1 0 0801650 BACTERIOLOGY CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 1 0
ASK
Publication
RD191001100 ELISA Human , Leptin , Clinical Range Biovendor 96 wells (1 kit) 241 RD191001100 ELISA Human , Leptin , Clinical Range Biovendor 96 wells (1 kit) 241
ASK
Publication
24053 Primary antibody CIDE-A Antibody, Source Rabbit, Species Reactivity It has no cross activity to CIDE-B. SignalWay Antibody S.A.B 100ug 364 24053 Primary antibody CIDE-A Antibody, Source Rabbit, Species Reactivity It has no cross activity to CIDE-B. SignalWay Antibody S.A.B 100ug 364
ASK
Publication
24054 Primary antibody CIDE-A Antibody, Source Rabbit, Species Reactivity It has no cross activity to CIDE-B. SignalWay Antibody S.A.B 100ug 364 24054 Primary antibody CIDE-A Antibody, Source Rabbit, Species Reactivity It has no cross activity to CIDE-B. SignalWay Antibody S.A.B 100ug 364
ASK
Publication
24055 Primary antibody CIDE-B Antibody, Source Rabbit, Species Reactivity It has no cross activity to CIDE-A. SignalWay Antibody S.A.B 100ug 364 24055 Primary antibody CIDE-B Antibody, Source Rabbit, Species Reactivity It has no cross activity to CIDE-A. SignalWay Antibody S.A.B 100ug 364
ASK
Publication
EKIN-400 EnzyChrom™ Kinase Assay Kit, Rapid mix-and-measure procedure for determination of kinase activity and high-throµghput screening for kinase inhibitors by fluorimetric (530nm 590nm) method Bioassays 400Tests 250 EKIN-400 EnzyChrom™ Kinase Assay Kit, Rapid mix-and-measure procedure for determination of kinase activity and high-throµghput screening for kinase inhibitors by fluorimetric (530nm 590nm) method Bioassays 400Tests 250 Publication
K335-100 SOD Activity Assay Kit 100 assays Biovision 100 assays 230.58 K335-100 SOD Activity Assay Kit 100 assays Biovision 100 assays 230.58 Publication
M1222 MarkerGeneTMFluorescent Alkaline Phosphatase Assay Kit, Allows fast and easy measurement of Alkaline Phosphatase activity in vitro, in cell preparations or in vivo using the substrate fluorescein diph MarkerGene 355 M1222 MarkerGeneTMFluorescent Alkaline Phosphatase Assay Kit, Allows fast and easy measurement of Alkaline Phosphatase activity in vitro, in cell preparations or in vivo using the substrate fluorescein diph MarkerGene 355
ASK
Publication
ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores US Biomax 231 ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores US Biomax 231
ASK
Publication
291-58601 Alkaline Phospatase (ALP) Assay Alkaline Phosphatase (ALP) is distributed in a variety of tissues such as liver, bone, and small intestine in animals. The change of the enzyme activity in tissues is a B-Bridge 900 tests 233.1 291-58601 Alkaline Phospatase (ALP) Assay Alkaline Phosphatase (ALP) is distributed in a variety of tissues such as liver, bone, and small intestine in animals. The change of the enzyme activity in tissues is a B-Bridge 900 tests 233.1
ASK
Publication
M0259 MarkerGeneTM in vivo lacZ beta Galactosidase Intracellular Detection Kit, Allows ultra sensitive detection of ß galactosidase activity in live mammalian, yeast, bacterial, or plant cells. Especially u MarkerGene 315 M0259 MarkerGeneTM in vivo lacZ beta Galactosidase Intracellular Detection Kit, Allows ultra sensitive detection of ß galactosidase activity in live mammalian, yeast, bacterial, or plant cells. Especially u MarkerGene 315 Publication
SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores US Biomax 456 SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
EASTR-100 EnzyChrom™ Aspartate Transaminase Assay Kit, Quantitative determination of aspartate transaminase activity at 340nm. Procedure 10 min. Kit size 100 tests. Detection limit 2 U L. Shelf life 6 month Bioassays 100tests 296 EASTR-100 EnzyChrom™ Aspartate Transaminase Assay Kit, Quantitative determination of aspartate transaminase activity at 340nm. Procedure 10 min. Kit size 100 tests. Detection limit 2 U L. Shelf life 6 month Bioassays 100tests 296 Publication
ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores US Biomax 456 ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores US Biomax 456
ASK
Publication
orb82514 FIV Core Ag, recombinant protein Feline Immunodeficiency Virus (FIV) Core Antigen, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 100 768 orb82514 FIV Core Ag, recombinant protein Feline Immunodeficiency Virus (FIV) Core Antigen, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 100 768
ASK
Publication
OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231 OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231
ASK
Publication
CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331 FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331
ASK
Publication
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores US Biomax 231 LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores US Biomax 231
ASK
Publication
LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266 ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266
ASK
Publication
OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores US Biomax 266 TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores US Biomax 266
ASK
Publication
UT721 Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases 72 cores US Biomax 266 UT721 Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases 72 cores US Biomax 266
ASK
Publication
IQ449 Mouse Anti-Lipoprotein Lipase (LPL) Target Antigen Lipoprotein Lipase (LPL) Host Isotype Mouse IgG Application Inhibition of LPL activity, ELISA, immuno-affinity work Imunquest 0.1ml (1mg/ml) 492 IQ449 Mouse Anti-Lipoprotein Lipase (LPL) Target Antigen Lipoprotein Lipase (LPL) Host Isotype Mouse IgG Application Inhibition of LPL activity, ELISA, immuno-affinity work Imunquest 0.1ml (1mg/ml) 492
ASK
Publication
BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456
ASK
Publication
BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456
ASK
Publication
BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231 BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231
ASK
Publication
BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781 FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781
ASK
Publication
FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores US Biomax 167 FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores US Biomax 167
ASK
Publication
KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 397 LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 397
ASK
Publication
LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516 LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516
ASK
Publication
LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456 MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516 MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516
ASK
Publication
MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231 MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231
ASK
Publication
MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231
ASK
Publication
OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278 PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278
ASK
Publication
RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231
ASK
Publication
ST1002 Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 ST1002 Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
M0795 MarkerGeneTM Live Dead Assay Kit, Allows fast and easy measurement of both living and dead cells by measuring intracellular esterase activity(live cells) and staining of nucleic acid in chromatin (dea MarkerGene 299 M0795 MarkerGeneTM Live Dead Assay Kit, Allows fast and easy measurement of both living and dead cells by measuring intracellular esterase activity(live cells) and staining of nucleic acid in chromatin (dea MarkerGene 299
ASK
Publication
182-01471 RANK Ligand Soluble, Human, recombinant (RANKL) Source Human RANK ligand cDNA expressed in E. coli Appearance Lyophilized powder (carrier free) Molecular weight 20,000 Biological Activity The B-Bridge 10 ug 493.5 182-01471 RANK Ligand Soluble, Human, recombinant (RANKL) Source Human RANK ligand cDNA expressed in E. coli Appearance Lyophilized powder (carrier free) Molecular weight 20,000 Biological Activity The B-Bridge 10 ug 493.5
ASK
Publication
186-01474 RANK Ligand Soluble, Human, recombinant (RANKL) Source Human RANK ligand cDNA expressed in E. coli Appearance Lyophilized powder (carrier free) Molecular weight 20,000 Biological Activity The B-Bridge 50 ug 1975.05 186-01474 RANK Ligand Soluble, Human, recombinant (RANKL) Source Human RANK ligand cDNA expressed in E. coli Appearance Lyophilized powder (carrier free) Molecular weight 20,000 Biological Activity The B-Bridge 50 ug 1975.05
ASK
Publication
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397 BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397
ASK
Publication
BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores US Biomax 231 BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores US Biomax 231
ASK
Publication
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 US Biomax 88 BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 US Biomax 88
ASK
Publication
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88 BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88
ASK
Publication
CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293 FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293
ASK
Publication
KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231 LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231
ASK
Publication
LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231 LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231
ASK
Publication
LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278 BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278
ASK
Publication
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231 BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231
ASK
Publication
BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456 BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456
ASK
Publication
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231 BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231
ASK
Publication
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LC1008 Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 LC1008 Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753 LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753
ASK
Publication
LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429 ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267 SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231 ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231
ASK
Publication
ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266 HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266
ASK
Publication
LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231 LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231
ASK
Publication
OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456 OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456
ASK
Publication
T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90 T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267 TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
orb82396 Toxoplasma gondii GRA8, recombinant protein Toxoplasma gondii GRA8, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 1 mg 784 orb82396 Toxoplasma gondii GRA8, recombinant protein Toxoplasma gondii GRA8, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 1 mg 784
ASK
Publication
E0552h ELISA kit CLGI,Collagenase inhibitor,EPA,Erythroid-potentiating activity,Fibroblast collagenase inhibitor,Homo sapiens,Human,Metalloproteinase inhibitor 1,TIMP,TIMP1,TIMP-1,Tissue inhibitor of metall EIAab 96T 706.65 E0552h ELISA kit CLGI,Collagenase inhibitor,EPA,Erythroid-potentiating activity,Fibroblast collagenase inhibitor,Homo sapiens,Human,Metalloproteinase inhibitor 1,TIMP,TIMP1,TIMP-1,Tissue inhibitor of metall EIAab 96T 706.65
ASK
Publication
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267 CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487 GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487
ASK
Publication
LC10011 Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 LC10011 Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88 MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88
ASK
Publication
MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231 MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231
ASK
Publication
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185 ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210 ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90 T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T141 Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T141 Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
M1049 MarkerGeneTM Live Cell Fluorescent Reactive Oxygen Species Detection Kit, for the detection of Reacive Oxygen Species (ROS, peroxidase activity) in live cells, 1 kit MarkerGene 299 M1049 MarkerGeneTM Live Cell Fluorescent Reactive Oxygen Species Detection Kit, for the detection of Reacive Oxygen Species (ROS, peroxidase activity) in live cells, 1 kit MarkerGene 299
ASK
Publication
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90 T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105 T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BL1921 Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 BL1921 Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
KD1921 Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 KD1921 Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
LV1921 Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 LV1921 Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
OV1921 Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 OV1921 Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456